Thank you!
We will contact you shortly
Authorized commercial representation. Direct manufacturer contracts.
We help U.S. brands evaluate innovative technologies and formulations, receive documentation under NDA, and launch private label or licensing projects.
All contracts and payments are executed directly between the client and the manufacturer.
AvalenPharm manages the process to reduce risk and timelines.
AvalenPharm is a U.S.-based business development company supporting U.S. nutraceutical brands in sourcing and evaluating EU manufacturing partners with differentiated technologies and formulations.
We act as an authorized commercial representative, facilitating NDA-based evaluation and commercial alignment. All contracts and payments are executed directly between the client and the manufacturer.
01
We support U.S. brands in:
Identifying relevant EU manufacturers based on portfolio strategy and market focus
Receiving technical documentation under NDA
Aligning commercial parameters such as MOQ, timelines, and supply formats
Advancing projects efficiently toward direct manufacturer engagement
02
Our approach is structured and transparent:
1. Portfolio fit assessment
2. NDA-based documentation review
3. Commercial and operational alignment with the manufacturer
4. Direct contract execution between the client and the manufacturer
5. Ongoing coordination through launch readiness
02
Our approach is structured and transparent:
1. Portfolio fit assessment
2. NDA-based documentation review
3. Commercial and operational alignment with the manufacturer
4. Direct contract execution between the client and the manufacturer
5. Ongoing coordination through launch readiness
03
Our business model is built on transparency and risk reduction.
• NDA-based evaluation• Direct contracts and payments executed with manufacturers• No intermediaries in the supply chain• One U.S.-based point of contact throughout the process
This structure allows U.S. companies to explore EU manufacturing opportunities with confidence, clarity, and control.
E-mail: